CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 34 enrolled
Drug / intervention
Salsalate +1 moredrug
Likely dose
Salsalate 2gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03222206
NCT03222206Phase 4Completed
CompareCT.gov

The Comparison of Effect Between Salsalate and Placebo in Osteoarthritis With Nonalcoholic Fatty Liver Disease: Investigator Initiated Randomized Placebo-controlled Double-blind, Pilot Study

Korea University Guro Hospital·interventional·Posted Jul 19, 2017·Updated Aug 22, 2019

In Brief

A Phase 4 clinical trial evaluating Salsalate and Placebo for Non Alcoholic Fatty Liver and Osteo Arthritis. Completed, enrolled 34 participants across 1 site.

Detailed Summary

This Study purpose to verify change of variety factors that the cause of nonalcoholic fatty liver disease and its process through salsalate injection to osteoarthritis patient who has non alcoholic fatty liver

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNon Alcoholic Fatty Liver, Osteo Arthritis
CountriesSouth Korea
CollaboratorsKuhnil Pharmaceutical Co., Ltd.

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedJul 19, 2017
Enrollment StartNov 8, 2017
Primary CompletionFeb 22, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.0 years ago

Interventions

Salsalatedrug

1. Medicate salsalate 2g/day after run-in period 2. Check side effect after 1 month and Control dosage (2g/day or 3g/day) 3. Check side effect after 2 month

Placeboother

1. Medicate placebo 2g/day after run-in period 2. Check side effect after 1 month and Control dosage (2g/day or 3g/day) 3. Check side effect after 2 month